Sugar.fit
A diabetes reversal program, including personalized 1-on-1 calls with health counselors, reducing medication, and increasing weight loss.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | $5.0m Valuation: $55.0m | Series A | |
| Total Funding | 000k | ||
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 146 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Sugarfit operates in the healthcare sector, focusing on personalized solutions for reversing Type 2 and Prediabetes by addressing the root causes of metabolic health issues. The company serves individuals diagnosed with Type 2 Diabetes or those at risk of developing the condition, offering a comprehensive approach that includes consultations with diabetes experts, continuous glucose monitoring, fitness, and mindfulness programs. Sugarfit's business model revolves around providing tailored healthcare plans and consultations, which are monetized through subscription fees and one-time consultation charges. The market it operates in is the digital health and wellness sector, targeting a growing demographic concerned with diabetes management and prevention. The company leverages technology and expert guidance to deliver personalized care, aiming to improve the quality of life for its clients by helping them regain control over their health.
Keywords: Type 2 Diabetes, Prediabetes, metabolic health, personalized care, continuous glucose monitoring, fitness, mindfulness, digital health, diabetes management, healthcare.